NuVasive has announced the first surgeries with its Precept posterior fixation system (a minimally invasive spinal surgery system) have taken place in Japan. The company received regulatory Shonin approval for the products in July this year.
According to a press release, the approval furthers the company’s ability to participate in the world’s second largest spine market, where the extreme lateral interbody fusion (XLIF) approach and other posterior products were previously approved. The Precept posterior fixation system provides surgeons with the ability to treat a wide range of pathologies, all while offering ease of use. The press release also reports that the system offers the most advanced technologies in guide design, rod insertion, set screw delivery, and multiple reduction capabilities.
Alex Lukianov, NuVasive chairman and chief executive officer, says: “With the approval and launch of Precept, we can introduce Japanese surgeons to additional innovation within our comprehensive portfolio of procedurally integrated spine solutions.”
